Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains

Hum Gene Ther. 1994 Nov;5(11):1315-24. doi: 10.1089/hum.1994.5.11-1315.

Abstract

A variety of genetic therapies or intracellular immunization techniques hold promise as modalities to inhibit human immunodeficiency virus type 1 (HIV-1) replication in vivo. We have recently demonstrated that a single-chain variable fragment (SFv) construct, derived from a monoclonal antibody that binds to the HIV-1 regulatory protein Rev, can be expressed intracellularly and potently inhibits HIV-1 replication. This single-chain intracellular antibody, which avidly binds to the effector domain of Rev, is now demonstrated to dramatically inhibit various diverse laboratory and primary clinical strains of HIV-1. Potent suppression of HIV-1 replication by this modality is maintained over several months in long-term cultures. As well, the intracellular expression of anti-Rev SFv is shown to alter HIV-1 replication by specifically affecting Rev function. Importantly, no alterations in HIV-1 internalization, reverse transcription, or initial transcription of multiply spliced viral mRNAs are demonstrated in SFv-immunized cells, as compared to controls. Thus, these studies extend the understanding of the molecular mechanisms involved in the inhibition of lentivirus replication, by these intracellular antibody constructs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / genetics
  • Antibodies, Monoclonal / immunology*
  • Antiviral Agents / pharmacology*
  • Base Sequence
  • DNA, Viral / isolation & purification
  • Gene Expression Regulation, Viral / drug effects
  • Gene Products, rev / antagonists & inhibitors*
  • Gene Products, rev / immunology
  • Gene Products, rev / physiology
  • HIV Antibodies / chemistry
  • HIV Antibodies / genetics
  • HIV Antibodies / immunology*
  • HIV-1 / drug effects*
  • HIV-1 / immunology
  • HIV-1 / physiology
  • HeLa Cells
  • Humans
  • Immunization, Passive / methods*
  • Immunoglobulin Fragments / genetics
  • Immunoglobulin Fragments / pharmacology*
  • Immunoglobulin Variable Region / genetics
  • Immunoglobulin Variable Region / pharmacology*
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Proviruses / isolation & purification
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology*
  • Recombinant Proteins
  • Single-Chain Antibodies
  • Transfection
  • Virus Replication / drug effects*
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents
  • DNA, Viral
  • Gene Products, rev
  • HIV Antibodies
  • Immunoglobulin Fragments
  • Immunoglobulin Variable Region
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • Single-Chain Antibodies
  • anti-HIV-1 Rev SFv
  • rev Gene Products, Human Immunodeficiency Virus